# Dexmedetomidine and Blood Coagulation

> **NCT04269278** · — · COMPLETED · sponsor: **Seoul National University Bundang Hospital** · enrollment: 11 (actual)

## Conditions studied

- Blood Coagulation Disorder

## Interventions

- **DRUG:** 0 ul of dexmedetomidine
- **DRUG:** 0.25 ul of dexmedetomidine
- **DRUG:** 0.5 ul of dexmedetomidine
- **DRUG:** 0.75 ul of dexmedetomidine

## Key facts

- **NCT ID:** NCT04269278
- **Lead sponsor:** Seoul National University Bundang Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-12
- **Primary completion:** 2020-12-30
- **Final completion:** 2020-12-30
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04269278

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04269278, "Dexmedetomidine and Blood Coagulation". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04269278. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*